🚀 VC round data is live in beta, check it out!
Zepp Health Valuation Multiples
Discover revenue and EBITDA valuation multiples for Zepp Health and similar public comparables like Affluent Medical, Quantum-Si, Onward Medical, Profound Medical and more.
Zepp Health Overview
About Zepp Health
Zepp Health Corp is engaged in the business of manufacturing smart health wearable products. The company operates in one segment which is Amazfit-branded products. The product portfolio includes smartwatches and fitness bands.
Founded
2014
HQ
Employees
765
Website
Financials (LTM)
EV
$406M
Zepp Health Financials
Zepp Health reported last 12-month revenue of $281M and negative EBITDA of ($16M).
In the same LTM period, Zepp Health generated $108M in gross profit, ($16M) in EBITDA losses, and had net loss of ($28M).
Revenue (LTM)
Zepp Health P&L
In the most recent fiscal year, Zepp Health reported revenue of $183M and EBITDA of ($47M).
Zepp Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $281M | XXX | $183M | XXX | XXX | XXX |
| Gross Profit | $108M | XXX | $70M | XXX | XXX | XXX |
| Gross Margin | 39% | XXX | 38% | XXX | XXX | XXX |
| EBITDA | ($16M) | XXX | ($47M) | XXX | XXX | XXX |
| EBITDA Margin | (6%) | XXX | (26%) | XXX | XXX | XXX |
| EBIT Margin | (7%) | XXX | (26%) | XXX | XXX | XXX |
| Net Profit | ($28M) | XXX | ($76M) | XXX | XXX | XXX |
| Net Margin | (10%) | XXX | (41%) | XXX | XXX | XXX |
| Net Debt | — | — | $88M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Zepp Health Stock Performance
Zepp Health has current market cap of $235M, and enterprise value of $406M.
Market Cap Evolution
Zepp Health's stock price is $16.33.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $406M | $235M | 0.0% | XXX | XXX | XXX | $-5.27 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialZepp Health Valuation Multiples
Zepp Health trades at 1.4x EV/Revenue multiple, and (25.5x) EV/EBITDA.
EV / Revenue (LTM)
Zepp Health Financial Valuation Multiples
As of April 20, 2026, Zepp Health has market cap of $235M and EV of $406M.
Equity research analysts estimate Zepp Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Zepp Health has a P/E ratio of (8.5x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $235M | XXX | $235M | XXX | XXX | XXX |
| EV (current) | $406M | XXX | $406M | XXX | XXX | XXX |
| EV/Revenue | 1.4x | XXX | 2.2x | XXX | XXX | XXX |
| EV/EBITDA | (25.5x) | XXX | (8.6x) | XXX | XXX | XXX |
| EV/EBIT | (22.2x) | XXX | (8.6x) | XXX | XXX | XXX |
| EV/Gross Profit | 3.8x | XXX | 5.8x | XXX | XXX | XXX |
| P/E | (8.5x) | XXX | (3.1x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (15.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Zepp Health Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Zepp Health Margins & Growth Rates
Zepp Health's revenue in the last 12 month grew by 24%.
Zepp Health's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.2M for the same period.
Zepp Health's rule of 40 is 31% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Zepp Health's rule of X is 73% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Zepp Health Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 24% | XXX | 42% | XXX | XXX | XXX |
| EBITDA Margin | (6%) | XXX | (26%) | XXX | XXX | XXX |
| EBITDA Growth | (196%) | XXX | (43%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 31% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 73% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 19% | XXX | 25% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 14% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 15% | XXX | 25% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 64% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Zepp Health Public Comps
See public comps and valuation multiples for other Wearables and Medical Devices comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Zepp Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Affluent Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Quantum-Si | XXX | XXX | XXX | XXX | XXX | XXX |
| Onward Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Profound Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| Utah Medical | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Zepp Health M&A Activity
Zepp Health acquired XXX companies to date.
Last acquisition by Zepp Health was on XXXXXXXX, XXXXX. Zepp Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Zepp Health
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialZepp Health Investment Activity
Zepp Health invested in XXX companies to date.
Zepp Health made its latest investment on XXXXXXXX, XXXXX. Zepp Health invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Zepp Health
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Zepp Health
| When was Zepp Health founded? | Zepp Health was founded in 2014. |
| Where is Zepp Health headquartered? | Zepp Health is headquartered in Netherlands. |
| How many employees does Zepp Health have? | As of today, Zepp Health has over 765 employees. |
| Who is the CEO of Zepp Health? | Zepp Health's CEO is Wang Wayne Huang. |
| Is Zepp Health publicly listed? | Yes, Zepp Health is a public company listed on NYSE. |
| What is the stock symbol of Zepp Health? | Zepp Health trades under ZEPP ticker. |
| When did Zepp Health go public? | Zepp Health went public in 2018. |
| Who are competitors of Zepp Health? | Zepp Health main competitors are Affluent Medical, Quantum-Si, Onward Medical, Profound Medical. |
| What is the current market cap of Zepp Health? | Zepp Health's current market cap is $235M. |
| What is the current revenue of Zepp Health? | Zepp Health's last 12 months revenue is $281M. |
| What is the current revenue growth of Zepp Health? | Zepp Health revenue growth (NTM/LTM) is 24%. |
| What is the current EV/Revenue multiple of Zepp Health? | Current revenue multiple of Zepp Health is 1.4x. |
| Is Zepp Health profitable? | No, Zepp Health is not profitable. |
| What is the current EBITDA of Zepp Health? | Zepp Health has negative EBITDA and is not profitable. |
| What is Zepp Health's EBITDA margin? | Zepp Health's last 12 months EBITDA margin is (6%). |
| What is the current EV/EBITDA multiple of Zepp Health? | Current EBITDA multiple of Zepp Health is (25.5x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.